Trial intelligence / Profile preview

Effects of Lipid Lowering Treatment on Steroid Synthesis

NCT00433823Phase 4Unknown

Sponsor
Bolu Abant Izzet Baysal University
Start
Jan 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of atorvastatin, ezetimibe in hypercholesterolemia, coronary heart disease (CHD), Peripheral Artery Disease (PAD), diabetes mellitus (DM), sponsored by Bolu Abant Izzet Baysal University. Status: unknown.

02

Drugs

atorvastatinezetimibe
03

Conditions

hypercholesterolemiacoronary heart disease (CHD)Peripheral Artery Disease (PAD)diabetes mellitus (DM)

Beyond the preview

Go deeper on NCT00433823.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00433823.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call